MAP3K9

JNK-IN-8 : In silico-in vitro discovery of untargeted kinase-inhibitor interactions from kinase-targeted therapies: A case study on the cancer MAPK signaling pathway

EX 527 :Sirtuin 1 inhibits TNF-α-mediated osteoclastogenesis of bone marrow- derived macrophages through both ROS generation and TRPV1 activation

Fluorescein-5-isothiocyanate : Assessment of Histiotrophic Nutrition Using Fluorescent Probes

Autophinib : Overexpression of the clock gene Per2 suppresses oral squamous cell carcinoma progression by activating autophagy via the PI3K/AKT/mTOR pathway

Semaxanib: Knockdown of ZEB1 suppressed the formation of vasculogenic mimicry and epithelial-mesenchymal transition in the human breast cancer cell line MDA-MB-231

Ribociclib: A hypothesis-driven approach identifies CDK4 and CDK6 inhibitors as candidate drugs for treatments of adrenocortical carcinomas

Ibrutinib : Resistance to Ibrutinib in B Cell Malignancies: One Size Does Not Fit All

AP20187 : Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy